Slide 1: Third Quarter 2016 Financial Results and Business Highlights
Third Quarter 2016 Financial Results and Business Highlights November 10, 2016
Slide 2: Forward-looking statements
Forward-looking statements “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This presentation c ontains forward-looking statements about the company and its products, including statements relating to components of the company’s long-term financial success and on
Slide 3: New Chief Financial Officer – Matt Plavan
New Chief Financial Officer – Matt Plavan Joined Arcadia on September 12, 2016 30 years of financial and executive leadership experience in healthcare, biotech and high technology companies Experienced in the areas of business operations, fiscal management and strategy, commercial partnering, M&A an
Slide 4: Three Key Areas
Comprehensive strategic review completed Three Key Areas Products Operations Organization 4
Slide 5: Products
Products Accelerate food and nutrition platform products, particularly non-GM Resistant Starch wheat Drive GM yield traits in corn and soybeans in North and South America Support partners advancing GM yield traits in rice, wheat and cotton 5
Slide 6: Operations
Operations Optimize cost structure to align with new strategic focus on high priority projects Additional investment and resourcing in certain GM traits will be done by our partners No additions to our yield and abiotic stress trait portfolio at this time 6
Slide 7: Organization
Organization Strengthen performance-driven organization across our company Ensure appropriate talent and expertise to support long-term success New management additions including new CFO and HR director 7
Slide 8: Q3 business highlights – Nutrition
Q3 business highlights – Nutrition GLA safflower oil • Revenue YTD is ahead of last year • FDA regulatory approval pending for use in pet food • Upon approval, may open a new market for Sonova GLA Resistant starch wheat • Field production underway for most advanced lines • Scaling up to support addi
Slide 9: Q3 business highlights – Agronomic yield
Q3 business highlights – Agronomic yield HB4 soybeans regulatory progress • Verdeca JV partner, Bioceres • USDA and FDA regulatory dossiers submitted and under review • Regulatory studies initiated for China and Europe Corn yield and stress trait development • Working with Dow AgroSciences • Third s
Slide 10: Revenue
Revenue Third Quarter First Nine Months % Favorable/ % Favorable/ 2016 2015 (Unfavorable) 2016 2015 (Unfavorable) Product revenue 102 123 (17%) 422 383 10% License revenue 218 214 2% 510 773 (34%) Contract research and government 755 1,486 (49%) 1,716 2,912 (41%) grants Total revenues 1,075 1,823 (4
Slide 11: P&L highlights
P&L highlights Third Quarter First Nine Months % Favorable/ % Favorable/ 2016 2015 (Unfavorable) 2016 2015 (Unfavorable) Total revenues 1,075 1,823 (41%) 2,648 4,068 (35%) Cost of product revenues 60 61 2% 242 223 (9%) R&D expense 2,255 3,179 29% 6,673 7,097 6% SG&A expense 2,687 2,818 5% 8,882 8,24
Slide 12: Thank you!
®D Arcadia BIOS CIEN CE S&S Thank you!